Core Laboratories N.V.

Core Laboratories N.V. (CLB) Market Cap

Core Laboratories N.V. has a market capitalization of $759.8M.

Financials based on reported quarter end 2025-12-31

Price: $16.50

-0.42 (-2.48%)

Market Cap: 759.80M

NYSE · time unavailable

CEO: Lawrence V. Bruno

Sector: Energy

Industry: Oil & Gas Equipment & Services

IPO Date: 1995-09-21

Website: https://www.corelab.com

Core Laboratories N.V. (CLB) - Company Information

Market Cap: 759.80M · Sector: Energy

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.

Analyst Sentiment

50%
Hold

Based on 3 ratings

Analyst 1Y Forecast: $0.00

Average target (based on 2 sources)

Consensus Price Target

Low

$17

Median

$26

High

$32

Average

$25

Potential Upside: 51.5%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 CORE LABORATORIES INC (CLB) — Investment Overview

🧩 Business Model Overview

Core Laboratories serves the upstream oil & gas industry with proprietary reservoir characterization and production-optimization services, primarily focused on evaluating rock/fluid properties and improving field performance. The value chain typically starts with customer needs tied to reservoir decisions (e.g., how to develop, stimulate, or manage production), proceeds through data-driven laboratory work and specialized technical services, and culminates in recommendations that influence reservoir economics.

Customer stickiness is reinforced by the fact that CLB’s deliverables are not merely “one-off” measurements; they are inputs into longer-lived reservoir development and operational decisions. Repeat engagement emerges as reservoir teams revisit characterization assumptions, validate performance, and refine stimulation or production strategies across the life of an asset.

💰 Revenue Streams & Monetisation Model

Revenue is driven by a blend of transaction-based service work and ongoing engagements that can become more recurring in nature when customers rely on CLB’s technical frameworks and data interpretation. Monetisation benefits from differentiation in sample analysis, interpretation, and decision support—services that command pricing power relative to commodity lab testing because the outputs are tied to reservoir value creation.

Margin drivers center on (1) utilization of specialized laboratory capacity and technical personnel, (2) the degree of repeatability in analytical workflows and software-driven interpretation, and (3) the mix between higher-value interpretive work and lower-margin logistical or sample-handling components. Over a cycle, operating leverage can emerge when utilization normalizes, but the model remains sensitive to upstream capital spending because customer demand is tied to well and reservoir activity.

🧠 Competitive Advantages & Market Positioning

The principal moat is switching costs and intangible assets built around technical methods, datasets, calibration, and interpretive know-how. Reservoir characterization decisions are high-stakes: operational outcomes depend on accurate rock/fluid property models, and changing providers can introduce model inconsistency, require re-validation, and slow decision timelines.

CLB’s competitive strength is rooted in:

  • Specialized technical know-how accumulated through proprietary methodologies and practical application across reservoir types.
  • Operational integration into customer workflows—reservoir engineers and operators often embed CLB outputs into field development planning and production optimization.
  • Data and intellectual capital that is difficult to replicate quickly, supporting repeat engagements and improved decision confidence.

While competitors may offer alternative laboratory services, winning work repeatedly is difficult because customers value continuity of methodology and interpretive consistency. That dynamic typically protects share in the absence of major technology displacement or sustained declines in upstream activity.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is supported by structural demand for more efficient reservoir development rather than by pure volume expansion. Key drivers include:

  • Technological refinement in upstream operations: as operators pursue lower-cost barrels, they rely more heavily on reservoir characterization to de-risk development and stimulation plans.
  • Complexity of resource bases: unconventional and heterogeneous reservoirs require better data interpretation and improved recovery modeling, increasing the value of specialized analytics.
  • Lifecycle optimization: demand extends beyond initial development into production management, where reservoir updates and validation can recur over time.
  • Digitalization of reservoir workflows: integration of laboratory insights with modeling and analytics supports ongoing use of CLB’s frameworks, potentially increasing both engagement depth and per-project value.

TAM expansion is primarily linked to the expanding need for improved recovery and operational efficiency across mature fields and technically complex reservoirs. Even without a strong “macro” up-cycle, the industry’s emphasis on optimizing existing assets tends to sustain a floor of technical services demand.

⚠ Risk Factors to Monitor

  • Commodity-cycle sensitivity: upstream capital expenditure influences exploration and production activity levels, directly affecting demand for reservoir services.
  • Customer concentration and project timing: large operators can concentrate spending decisions and shift budgets between service providers, creating lumpy volumes.
  • Technology substitution: advances in alternative sensing, in-situ measurements, or proprietary customer internal modeling could reduce reliance on third-party lab interpretation if replacement becomes credible and faster.
  • Regulatory and environmental constraints: changes in permitting, emissions requirements, and field operations can alter stimulation and production plans, indirectly impacting service needs.
  • Execution and capacity utilization: specialized labs require disciplined cost control; prolonged low utilization can pressure margins.

📊 Valuation & Market View

Equity investors typically value this industry through cash-flow and earnings power rather than asset intensity, often using metrics such as EV/EBITDA or enterprise value versus operating cash flow. The valuation framework commonly reflects:

  • Expected operating leverage as utilization improves through the commodity cycle.
  • Durability of technical differentiation (how effectively switching costs sustain margins through downturns).
  • Balance between service cyclicality and repeat engagement that can dampen volatility relative to purely transactional offerings.

Key variables that move valuation multiples include normalized margin outlook, backlog/engagement visibility where measurable, and confidence in the company’s ability to maintain pricing discipline and technical share during industry up- and down-cycles.

🔍 Investment Takeaway

Core Laboratories offers a defensible position in upstream reservoir services driven by intangible technical capital and switching costs. The business converts specialized laboratory and interpretive expertise into decision inputs that remain embedded in reservoir planning and production optimization workflows. The investment case centers on the durability of its moat through industry cycles and the continued need for reservoir de-risking and efficiency gains as reservoirs grow more complex and operators prioritize recovery and cost control.


⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"For the fiscal year ending December 31, 2025, CLB reported revenues of $138.3M and net income of $7.1M, leading to an earnings per share (EPS) of $0.15. Despite a modest revenue growth forecast, the company’s profitability is improving, indicated by an operating cash flow of $7.9M and a positive free cash flow of $4.3M, which suggests efficient management of capital expenditures. The balance sheet shows total assets of $597M against total liabilities of $317.2M, yielding total equity of $279.8M. This indicates a healthy equity position but a net debt of $183.5M could be a concern in a rising interest rate environment. Shareholder returns have been minimal with a 1-year price change of only +0.96%, and while dividends paid are $0.04 annually, this is overshadowed by the price performance, resulting in low total shareholder return. The stock is currently priced at $15.71, with a target consensus price of $25, reflecting potential upside. Overall, the company's performance indicates moderate growth potential, and while it is navigating through some challenges, there are positive signs in its cash flow management."

Revenue Growth

Caution

Revenues at $138.3M show modest growth.

Profitability

Neutral

Net income of $7.1M indicates improving profitability.

Cash Flow Quality

Positive

Positive free cash flow of $4.3M demonstrates solid cash management.

Leverage & Balance Sheet

Fair

Net debt presents potential risks, but equity is strong.

Shareholder Returns

Neutral

Minimal total return despite dividend payments; low price appreciation.

Analyst Sentiment & Valuation

Fair

Current price below target median suggests potential for valuation improvement.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Management delivered modest top-line growth but acknowledged multiple margin headwinds in Q4. Reservoir Description expanded margins +60 bps sequentially to 14%, yet Production Enhancement margins fell to 7% from 11% in Q3 due to an Asia Pacific potentially uncollectible receivable provision and tariff-driven higher raw material costs. The company also highlighted operational disruption: freezing conditions in early January (plus Europe/Mediterranean weather) are expected to create additional Q1 2026 revenue and margin headwinds. Q1 guidance points to ~9% operating margins and EPS of $0.11-$0.15, explicitly excluding FX and assuming a 25% tax rate, while also warning interest expense should rise as a $50M term loan carries a ~+200 bps spread vs the retired fixed-rate notes. In Q&A, analyst pressure focused on Venezuela; management leaned toward optionality (legacy data + mobile lab follow-through) but signaled near-term spend may initially favor metal-heavy remediation work rather than Core’s services.

AI IconGrowth Catalysts

  • Reservoir description demand: Q4 revenue up 5% vs prior quarter/2025 and up 6% vs Q4 last year (rock & fluid analysis across global labs)
  • Completion diagnostic services: sequential improvement driven by increased demand for completion diagnostics in the US and several international regions
  • Production enhancement diagnostics: Q4 revenue up >8% year over year (completion diagnostic services across onshore/offshore)

Business Development

  • South America: geomechanics/reservoir characterization study for Palagua field in Colombia (waterflood + sand production mitigation; core-calibrated models using Nitro Digital Rock Tomography workstreams)
  • South America energy transition: Brazil carbon capture & storage initiative—~100 meters of core evaluated using Nitro Digital Rock Tomography (CO2-rock/fluid interaction analysis ongoing)
  • Middle East 2025 plug & abandonment: national oil company supported with proprietary Pulverizer system (tubing-conveyed perforating; ~100 ft pulverizer then additional ~100 ft polarizer deployments)
  • US unconventional operators (Q4): diagnostic evaluations of emerging plugless completion designs using SpectraStim proppant tracer diagnostics (diverter-based stage isolation and stimulation verification)

AI IconFinancial Highlights

  • Revenue: $138.3M in Q4 2025 (+3% sequential; +7% YoY)
  • EPS (ex items): $0.21 for Q4 2025 vs $0.22 in both prior quarter and Q4 last year
  • EPS (GAAP): $0.15 for 2025 (Q4 GAAP net income $7.1M)
  • Operating margin (Reservoir Description, ex items): 14% in Q4 2025, expanding sequentially by +60 bps
  • Production Enhancement operating margin (ex items): 7% in Q4 2025 vs 11% in Q3 and 4% in Q4 2024; sequentially pressured by Asia Pacific provision + tariff-driven raw material cost increases
  • Service revenue (Q4): $107.0M (+6% sequential; +11% YoY)
  • Product sales (Q4): $31.3M (-6% sequential; -4% YoY) driven by lower US onshore completion activity
  • Cost of services ex items: 75% of service revenue in Q4 (vs 74% prior quarter; 76% prior-year quarter); sequential increase due to labor costs + pass-through revenue
  • Cost of sales ex items: 94% of revenue in Q4 vs 88% last quarter (sequential increase due to fixed-cost absorption on lower revenue base and higher bad debt expense)
  • 2025 EBIT ex items: $58.7M (-10% vs 2024); GAAP EBIT $56.5M
  • Tax: Q4 effective tax rate assumed 25% (ex items); GAAP tax expense $6.0M in Q4; 2025 GAAP effective tax rate 29%; management expects ~25% effective tax rate for 2026
  • Interest expense outlook: term loan rate expected ~+200 bps vs retired fixed-rate notes due to SOFR linkage

AI IconCapital Funding

  • Q4 share repurchases: 3,633,000+ shares for ~$5.7M
  • Full-year 2025 share repurchases: 1,200,000 shares for ~$15.5M
  • Q4: returned free cash via quarterly dividend + buybacks (no explicit dollar dividend stated in transcript)
  • Debt/cash (12/31/2025): long-term debt $113.0M; cash $22.8M; net debt $90.2M; leverage ratio ended at 1.09
  • Funding event (01/12/2026): drew $50.0M on a term loan under credit facility to retire $45.0M 2021 senior notes (principal), remainder to cover related funding needs

AI IconStrategy & Ops

  • Operational hinge: managed cost structure through temporary geopolitical/sanctions disruptions affecting lab services tied to crude assay and maritime movement
  • Working capital: DSOs improved to 69 days (from 71); inventory down to $54.5M (-$3.7M sequential); inventory turns improved to 2.1 (from 2.0)
  • UK facility rebuild: related CapEx excluded from free cash flow; rebuilding CapEx covered by insurance
  • Production enhancement margin headwind drivers: Asia Pacific potentially uncollectible receivable provision (no further receivables at risk per management) and tariff-driven higher raw material costs
  • Technology execution: continued deployment/field adoption—Pulverizer/Polarizer in plug & abandonment; SpectraStim proppant tracer diagnostics for plugless completions

AI IconMarket Outlook

  • Q1 2026 guidance (full company): revenue $124M to $130M; operating income $9.7M to $12.2M; operating margin ~9%
  • Q1 2026 EPS guidance: $0.11 to $0.15 (excludes FX gains/losses; assumes effective tax rate 25%)
  • Q1 2026 segment guidance: Reservoir Description revenue $82M-$86M; operating income $6.8M-$8.2M; Production Enhancement revenue $42M-$44M; operating income $2.8M-$3.8M
  • Macro demand: IEA/EIA/OPEC+ crude demand growth forecast ~+0.9 to +1.4 million bpd in 2026 (slightly higher than prior forecast); US oil production ~13.6M bpd in 2026 (flat YoY)
  • Tariffs: management stated tariffs had not had significant impact on Reservoir Description; impact exists for Production Enhancement due to imported raw materials subject to tariffs

AI IconRisks & Headwinds

  • Geopolitical conflicts + evolving/expanded sanctions: negatively impacted assay laboratory services tied to trade/transport of crude and derived products
  • Commodity price volatility driven by geopolitical tensions and supply-demand balance concerns
  • Asia Pacific: provision for a potentially uncollectible receivable pressured Production Enhancement sequential margins; management: no further receivables at risk with this contract
  • Bad debt expense: cost of sales ex items increased sequentially, attributed partly to higher bad debt expense
  • Tariff-related cost increases: raw material costs rose in Production Enhancement operations; management described mitigation steps but did not quantify savings in transcript
  • Weather disruptions: severe North America freezing early January disrupted reservoir description and production enhancement client activities; adverse Europe/Med Sea weather suspended client crude assay work and damaged one Core Lab facility; management expects additional Q1 revenue and margin headwinds
  • US land: completion activity down vs 2025 (management expects improvement from current levels, but still down Y/Y); short-cycle activity remains sensitive to commodity prices
  • Venezuela question (Q&A): management emphasized legacy data monetization if operators return; near-term spend likely favors metal-heavy/pipe remediation companies more than Core Lab (operators may bring mobile lab capabilities to provide analysis)

Sentiment: MIXED

Note: This summary was synthesized by AI from the CLB Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (CLB)

© 2026 Stock Market Info — Core Laboratories N.V. (CLB) Financial Profile